Delivery Order SPE2DB22D3301-SPE2DB26FX3QK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Topiramate ER 100 mg capsules (30-count units) with a ceiling value of $1,438.42. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,365.81 to AmerisourceBergen Drug Corp for Topiramate ER 200 mg capsules (30-count units) on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a $8,189.46 delivery order to AmerisourceBergen Drug Corp for the supply of Topiramate ER 100 mg capsules (30-count) with a firm fixed price structure. This is a non-set-aside, competitively awarded contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of July 16, 2025. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Topiramate ER 100 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $3,003.47. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $6,195.98 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 100 mg capsules (30-count packages) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract was performed at the vendor's corporate office location in Conshohocken, Pennsylvania, and carries no set-aside designation. The delivery order represents a child contract action under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,341.04 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 200 mg capsules (30-count units). This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a competitively awarded, non-set-aside contract. The product will be delivered to Conshohocken, Pennsylvania, where the vendor maintains its corporate office. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Topiramate ER 100 mg capsules in 30-count units under a firm fixed-price contract with a ceiling value of $1,386.06. This is a non-set-aside, competitively awarded delivery order for pharmaceutical products to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Topiramate ER 50 mg capsules (30-count units) under a firm fixed price contract with a ceiling value of $2,140.45. The delivery order, which is non-competitive and carries an ultimate completion date of August 6, 2025, will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This contract represents a child order against...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order on September 15, 2025, by the Defense Logistics Agency (DLA) with a ceiling value of $21,008.23. The contract, which is not set-aside, calls for the delivery of Topiramate ER 200 mg capsules (30-count units), a neurological treatment medication. Performance will be completed at the vendor's Conshohocken facility with an ultimate completion...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $22,406.92, is for the delivery of 4,564,109,231 units of topiramate ER 100 mg capsules. The contract has an ultimate completion date of March 29, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX3QKDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Topiramate ER 100 mg capsules (30-count units) with a contract ceiling value of $8,032.67. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. As one of the primary vendors under the DLA's pharmaceutical prime vendor program, the company supplies a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains, including neurological treatments, pain management medications, and specialized healthcare commodities. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse medical supply requirements through open competition, with delivery orders ranging from small-value transactions to substantial orders exceeding $45,000, and it also serves additional federal customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 10/21/25 |